Progyny (PGNY) closed at $36.18 on November 13, 2026, down 1.1% from the previous close, on volume of 833,725 shares (30-day average 1,031,199).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 30, 2026 | Calendar Call Spread | 20-Nov : 18-Dec-26 30 C | 200 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
Progyny Earnings Call Highlights Growth, Cash Flow and Guidance
TipRanks (Sat, 14-Nov 8:37 PM ET)
Market Chameleon (Thu, 5-Nov 6:51 AM ET)
Progyny, Inc. Announces Third Quarter 2026 Results
Globe Newswire (Wed, 4-Nov 4:01 PM ET)
Globe Newswire (Wed, 28-Oct 9:51 AM ET)
New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model
Globe Newswire (Mon, 26-Oct 11:25 AM ET)
Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report
Globe Newswire (Wed, 21-Oct 10:43 AM ET)
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
Globe Newswire (Thu, 15-Oct 9:34 AM ET)
Globe Newswire (Wed, 7-Oct 8:28 AM ET)
Progyny, Inc. to Present at the Wells Fargo Healthcare Conference
Globe Newswire (Thu, 3-Sep 11:16 AM ET)
Progyny Delivers Strong Q1 2026: Gross Margin Hits Multiyear High Despite Large Client Exit
Market Chameleon (Fri, 8-May 5:45 AM ET)
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Progyny trades on the NASDAQ stock market under the symbol PGNY.
As of November 13, 2026, PGNY stock price declined to $36.18 with 833,725 million shares trading.
PGNY has a beta of -0.19, meaning it tends to be less sensitive to market movements. PGNY has a correlation of 0.00 to the broad based SPY ETF.
PGNY has a market cap of $2.66 billion. This is considered a Mid Cap stock.
Last quarter Progyny reported $341 million in Revenue and $.52 earnings per share. This beat revenue expectation by $699,136 and exceeded earnings estimates by $.06.
In the last 3 years, PGNY traded as high as $42.08 and as low as $13.39.
The top ETF exchange traded funds that PGNY belongs to (by Net Assets): IJR, AVUV, IWM, VTI, VB.
PGNY has outperformed the market in the last year with a price return of +48.2% while the SPY ETF gained +13.4%. PGNY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +39.7% and +23.9%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
PGNY support price is $35.68 and resistance is $37.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PGNY shares will trade within this expected range on the day.